Search
Descriptor English: Methyldopa
Descriptor Spanish: Metildopa
Descriptor metildopa
Entry term(s) alfa-metildopa
alfametildopa
metildopato
Scope note: Agonista adrenérgico alfa-2 con efectos sobre el sistema nervioso central y periférico. Su principal uso clínico es como un agente antihipertensor.
Descriptor Portuguese: Metildopa
Descriptor French: Méthyldopa
Entry term(s): Aldomet
Alphamethyldopa
Apo Methyldopa
Apo-Methyldopa
Dopamet
Dopegit
Dopegyt
Dopergit
Hydopa
Meldopa
Methyldopate
Nu Medopa
Nu-Medopa
Sembrina
alpha Methyl L Dopa
alpha Methyldopa
alpha-Methyl-L-Dopa
alpha-Methyldopa
Tree number(s): D02.092.311.200.538
D02.455.426.559.389.657.166.175.200.538
D12.125.072.050.685.400.600
D12.125.072.050.875.130.600
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D008750
Scope note: An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antihypertensive Agents
Sympatholytics
Adrenergic alpha-2 Receptor Agonists
Registry Number: 56LH93261Y
CAS Type 1 Name: L-Tyrosine, 3-hydroxy-alpha-methyl-
Public MeSH Note: 65; ALPHAMETHYLDOPA was see METHYLDOPA 1977-94
Online Note: use METHYLDOPA to search ALPHAMETHYLDOPA 1977-94
History Note: 65(63); ALPHAMETHYLDOPA was see METHYLDOPA 1977-94
DeCS ID: 8934
Unique ID: D008750
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1965/01/01
Date of Entry: 1999/01/01
Revision Date: 2018/07/02
Methyldopa - Preferred
Concept UI M0013626
Scope note An alpha-2 adrenergic agonist that has both central and peripheral nervous system effects. Its primary clinical use is as an antihypertensive agent.
Preferred term Methyldopa
Entry term(s) Alphamethyldopa
alpha Methyl L Dopa
alpha Methyldopa
alpha-Methyl-L-Dopa
alpha-Methyldopa
Meldopa - Narrower
Concept UI M0474250
Preferred term Meldopa
Methyldopate - Narrower
Concept UI M0013627
Preferred term Methyldopate
Dopegyt - Narrower
Concept UI M0371003
Preferred term Dopegyt
Entry term(s) Dopegit
Dopergit
Sembrina - Narrower
Concept UI M0474252
Preferred term Sembrina
Apo-Methyldopa - Narrower
Concept UI M0474247
Preferred term Apo-Methyldopa
Entry term(s) Apo Methyldopa
Dopamet - Narrower
Concept UI M0474248
Preferred term Dopamet
Aldomet - Narrower
Concept UI M0013628
Preferred term Aldomet
Hydopa - Narrower
Concept UI M0474249
Preferred term Hydopa
Nu-Medopa - Narrower
Concept UI M0474251
Preferred term Nu-Medopa
Entry term(s) Nu Medopa



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey